SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-175745
Filing Date
2019-06-18
Accepted
2019-06-18 17:05:03
Documents
7
Period of Report
2019-08-06
Effectiveness Date
2019-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d692159ddef14a.htm DEF 14A 362131
2 GRAPHIC g692159g11y77.jpg GRAPHIC 26592
3 GRAPHIC g692159g21j11.jpg GRAPHIC 24658
4 GRAPHIC g692159g22o22.jpg GRAPHIC 45992
5 GRAPHIC g692159g56z83.jpg GRAPHIC 16586
6 GRAPHIC g692159g57f70.jpg GRAPHIC 22487
7 GRAPHIC g692159g91s88.jpg GRAPHIC 32589
  Complete submission text file 0001193125-19-175745.txt   596461
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38327 | Film No.: 19904268
SIC: 2834 Pharmaceutical Preparations